1. Home
  2. IZEA vs CUE Comparison

IZEA vs CUE Comparison

Compare IZEA & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

N/A

Current Price

$3.67

Market Cap

60.5M

ML Signal

N/A

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$0.31

Market Cap

27.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IZEA
CUE
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.5M
27.1M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
IZEA
CUE
Price
$3.67
$0.31
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
55.8K
350.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.14
EPS
0.07
N/A
Revenue
$20,099,695.00
$9,287,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
$25.00
P/E Ratio
$53.00
N/A
Revenue Growth
N/A
69.16
52 Week Low
$1.68
$0.23
52 Week High
$5.86
$1.05

Technical Indicators

Market Signals
Indicator
IZEA
CUE
Relative Strength Index (RSI) 47.71 45.96
Support Level $3.48 $0.27
Resistance Level $4.28 $0.36
Average True Range (ATR) 0.18 0.03
MACD 0.03 0.00
Stochastic Oscillator 41.67 40.42

Price Performance

Historical Comparison
IZEA
CUE

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: